William J. Peters - Mar 16, 2022 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
CFO, EVP & Treasurer
Signature
/s/ William J. Peters
Stock symbol
AMPH
Transactions as of
Mar 16, 2022
Transactions value $
-$1,306,425
Form type
4
Date filed
3/18/2022, 06:57 PM
Previous filing
Mar 17, 2022
Next filing
May 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $731K +50.8K +44.49% $14.40 165K Mar 16, 2022 Direct
transaction AMPH Common Stock Sale -$1.6M -47K -28.51% $33.93 118K Mar 16, 2022 Direct F1
transaction AMPH Common Stock Sale -$129K -3.76K -3.19% $34.36 114K Mar 16, 2022 Direct F2
transaction AMPH Common Stock Tax liability -$171K -5K -4.38% $34.22 109K Mar 16, 2022 Direct F3
transaction AMPH Common Stock Tax liability -$142K -4.16K -3.81% $34.18 105K Mar 17, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Employee Stock Option (right to buy) Options Exercise $0 -50.8K -100% $0.00* 0 Mar 16, 2022 Common Stock 50.8K $14.40 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.24 to $34.235, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.24 to $34.66, inclusive.
F3 The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs.
F4 Shares subject to the option are fully vested and immediately exercisable.